David C Hastings's Net Worth
$30.5 Million
Who is David C Hastings?
David C Hastings has an estimated net worth of $30.5 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, Arbutus Biopharma Corp, Entasis Therapeutics Holdings Inc., SCYNEXIS INC, Unilife Corp, and Vascular Biogenics Ltd..
SEC CIK
David C Hastings's CIK is 0001237401
Past Insider Trading and Trends
2014 was David C Hastings's most active year for acquiring shares with 18 total transactions. David C Hastings's most active month to acquire stocks was the month of January. 2014 was David C Hastings's most active year for disposing of shares, totalling 21 transactions. David C Hastings's most active month to dispose stocks was the month of January. 2014 saw David C Hastings paying a total of $5,260,250.00 for 499,829 shares, this is the most they've acquired in one year. In 2014 David C Hastings cashed out on 950,000 shares for a total of $28,659,232.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INCYTE CORP (INCY) Snapshot price: $60.96
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$30.58 | -$8,862,363.20 | 8.5K |
Jun 4 - Jun 5
| |||
Form 4
|
—
|
0
|
$39.43 | -$14,536,619.52 | 8.5K |
Feb 13 - Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
$21.13 | -$2,807,000.00 | 8.5K |
Sep 6
| |||
Form 4
|
—
|
0
|
$14.56 | -$1,593,200.00 | 8.5K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
$11.43 | -$1,261,500.00 | 8.5K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +30.77% | 2K |
$10.24 | $20,480.00 | 8.5K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
| +160.00% | 4K |
$2.36 | $9,440.00 | 6.5K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
∞
| 2.5K |
$3.60 | $9,000.00 | 2.5K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +130.26% | 102.91K |
$2.31 | -$22,183.81 | 181.91K |
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
|
∞
| 79K |
—
|
—
| 79K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entasis Therapeutics Holdings Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -49.50K |
$2.20 | -$108,900.00 |
0
|
Jul 7 - Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
| +125.00% | 27.5K |
—
|
—
| 49.5K |
Jan 18
| |||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCYNEXIS INC (SCYX) Snapshot price: $1.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +99.21% | 23K |
—
|
—
| 46.18K |
Jun 20
| |||
Form 4
| +75.86% | 10K |
—
|
—
| 23.18K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +314.17% | 10K |
—
|
—
| 13.18K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +59.17% | 11.83K |
$1.69 | $19,999.46 | 31.83K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
∞
| 20K |
$1.75 | $35,000.00 | 20K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unilife Corp No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
∞
| 300K |
—
|
—
| 300K |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||